About the speaker

Doctor Daniel P Kelly

The Trustees of The University of Pennsylvania, Philadelphia (United States of America)
1 presentation
0 follower

2 more presentations in this session

Are the beneficial effects of SGLT2-inhibitors in heart failure dependent on enhanced ketone metabolism?

Speaker: Doctor B. Westenbrink (Groningen, NL)

Thumbnail

Cardiovascular and metabolic effects of treatment with the ketone body 3-hydroxybutyrate in patients with chronic heart failure.

Speaker: Doctor R. Nielsen (Aarhus, DK)

Thumbnail

Access the full session

Metabolic Dysfunction in Heart Failure: Can We Harness the Power of Ketones?

Speakers: Doctor D. Kelly, Doctor B. Westenbrink, Doctor R. Nielsen
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations